The Role of m6A RNA Modification in Moyamoya Disease
Learn more about:
Related Clinical Trial
Super-resolution Clinical Brain Ultrasound
Functional Disorders Moya Moya Young Patients
The Evolution and Prognosis of Moyamoya Disease
Florida Cerebrovascular Disease Biorepository and Genomics Center
Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease
Gut Microbiota in Patients With Moyamoya Disease
The Role of m6A RNA Modification in Moyamoya Disease
Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome
Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
Efficacy and Safety of rTMS for Cognitive Rehabilitation in Moyamoya Disease
Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery
NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients
Sevoflurane and Hyperperfusion Syndrome
The Safety and Efficacy of RIC on Adult Moyamoya Disease
Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease
Precision Bypass in Patients With Moyamoya Disease
Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients
Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy
The Effect of RIC on TIA/Stroke in Children With Moyamoya Disease
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients
Predicative Value of Multimodal MRI in Moyamoya Disease
Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke
Relationship Between Endothelial Progenitor Cells and Revascularization Effect of Moyamoya Disease
Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease